logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2011 or most recent year available

Part (vi) All stimulants (other than cocaine) inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium6.74.410.078.99010
Bulgaria::20.080.050
Czech Republic24.213.933.828.1150046
Denmark:5.941.252.9170
Germany::::::
Estonia::::::
Ireland141.2:29.429.4176
Greece:33.366.7:30
Spain::::::
France:25.0:75.040
Italy::::::
Cyprus25.0:50.025.040
Latvia::::::
Lithuania::::::
Luxembourg::::::
Hungary4.517.019.658.91124
Malta::::::
Netherlands9.44.723.562.48548
Austria60.012.016.012.0251
Poland2241039.526.520011
Portugal::::::
Romania25.025.025.025.047
Slovenia::::::
Slovakia7.922.039.430.724118
Finland35.011.735.018.41031
Sweden124.79.124.441.8825110
United Kingdom3::::::
Croatia:::::7
Turkey:16.722.261.1181
Norway26.216.414.54325612
Total22.212.829.435.63253270
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013